Sermorelin Acetate is the acetate-salt form of Sermorelin — a synthetic 29-residue peptide corresponding to the active N-terminal fragment of human growth hormone-releasing hormone, GHRH(1-29). The free peptide (CAS 86168-78-7) and its acetate salt (CAS 114466-38-5, the form typically sold commercially) are related but distinct identifiers — conflating them is one of the most common errors in peptide-vendor copy. Available in 10mg and 20mg for laboratory research use only.
HPLC certified
Independent analysis
Highest standard
Full traceability
Each order ships as a Sermorelin Acetate research compound, manufactured for laboratory use only.
| Compound | Sermorelin Acetate |
|---|---|
| Classification | Acetate salt of GHRH(1-29) |
| CAS (free peptide, Sermorelin) | 86168-78-7 |
| CAS (acetate salt, this compound) | 114466-38-5 (FDA UNII 00IBG87IQW) |
| Molecular Formula (free peptide) | C149H246N44O42S |
| Molecular Weight (free peptide) | 3,357.9 g/mol |
| Available Sizes | 10mg, 20mg |
| Purity | Not independently verified -- no batch-specific COA is currently published |
| Identity | Not independently confirmed by mass spectrometry or an equivalent method |
| Regulatory Status | Prescription GHRH(1-29) (Geref) was FDA-approved, then discontinued in 2009 for business reasons, not safety. Current RUO material carries no FDA approval |
| Intended Use | Laboratory research only (RUO) |
When your order arrives, match the lot number printed on the vial to the lot number on the COA before beginning any work. Until a batch-specific COA is published for this product, treat any purity or identity figure shown elsewhere on this listing as a supplier claim, not an independently verified result.
Sermorelin acetate is a 29-amino-acid GHRH fragment, not growth hormone itself — here's what actually raises GH levels and why Geref's FDA history doesn't carry over today.
What is Ipamorelin? See what research shows about its mechanism, potential benefits, safety signals, and current FDA regulatory status for researchers.
HCG and LH bind the exact same receptor — yet research shows they send measurably different signals once they do. Here's what's actually established about HCG's structure, mechanism, and the FDA's position on HCG weight-loss claims.
